Heparin Solid Dosage: Development Status and Positioning
Refocus efforts on tablet and capsule form (for both UFH and LMWH)
Niche indications to be pursued (unless partnered); enable fast track approval
Placebo controlled studies
Leverage significant safety database from PROTECT to arrive first to market
Practical dosage form has been demonstrated in primates; human testing to begin this year
Reasonable solid dosage form that is commercially viable